Cargando…

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans

The domestic ferret is a uniformly lethal model of infection for 3 species of Ebolavirus known to be pathogenic in humans. Reagents to systematically analyze the ferret host response to infection are lacking; however, the recent publication of a draft ferret genome has opened the potential for trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cross, Robert W, Speranza, Emily, Borisevich, Viktoriya, Widen, Steven G, Wood, Thomas G, Shim, Rebecca S, Adams, Ricky D, Gerhardt, Dawn M, Bennett, Richard S, Honko, Anna N, Johnson, Joshua C, Hensley, Lisa E, Geisbert, Thomas W, Connor, John H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249602/ https://www.ncbi.nlm.nih.gov/pubmed/30476250 http://dx.doi.org/10.1093/infdis/jiy455

Ejemplares similares

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates
por: Thi, Emily P., et al.
Publicado: (2015)

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate
por: Luke, Thomas, et al.
Publicado: (2018)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
por: Mire, Chad E., et al.
Publicado: (2015)

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
por: Cross, Robert W., et al.
Publicado: (2021)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002)

High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona
por: Honko, Anna N., et al.
Publicado: (2017)

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2017)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2019)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever
por: Rubins, Kathleen H, et al.
Publicado: (2007)

Euthanasia Assessment in Ebola Virus Infected Nonhuman Primates
por: Warren, Travis K., et al.
Publicado: (2014)

Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
por: Zeitlin, Larry, et al.
Publicado: (2021)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Evaluating Environmental Persistence and Disinfection of the Ebola Virus Makona Variant
por: Cook, Bradley W. M., et al.
Publicado: (2015)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
por: Cross, Robert W., et al.
Publicado: (2023)

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2012)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia
por: Kugelman, Jeffrey R., et al.
Publicado: (2015)

Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
por: Sullivan, Nancy J, et al.
Publicado: (2006)

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
por: Geisbert, Thomas W, et al.
Publicado: (2010)

Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain
por: Marzi, Andrea, et al.
Publicado: (2015)

Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus
por: Chan, Mable, et al.
Publicado: (2019)

Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques
por: de La Vega, Marc Antoine, et al.
Publicado: (2021)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™)
por: Qiu, Xiangguo, et al.
Publicado: (2014)

Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood
por: Schuit, Michael, et al.
Publicado: (2016)

Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model
por: Satterfield, Benjamin A., et al.
Publicado: (2019)

Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus
por: Garamszegi, Sara, et al.
Publicado: (2014)

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
por: Mire, Chad E., et al.
Publicado: (2016)

A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
por: Mire, Chad E, et al.
Publicado: (2020)

Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_36h4dsrcl5e309maao6am7e9qp